
Rebopag 25mg
Generic: Eltrombopag
Select Pack Size:
Selected: 28 Tablet/s
$220.00 total
About Rebopag 25mg
What is Rebopag 25mg?
Rebopag 25mg is an Indian brand of eltrombopag, a thrombopoietin receptor agonist that raises platelet counts. Each tablet contains eltrombopag 25 mg. It is made in India by MSN Laboratories.
What it is used for
According to the US FDA label for Promacta (DailyMed), eltrombopag is used for low platelets in persistent or chronic immune thrombocytopenia (ITP) in adults and children 1 year and older when other treatments were not enough, low platelets in chronic hepatitis C so that interferon treatment can start or continue, and severe aplastic anemia; it is not for myelodysplastic syndrome. The US label carries a boxed warning about serious liver injury, and about liver failure in people with hepatitis C who take it with interferon and ribavirin. Your doctor decides whether it suits you.
Packs and price
Rebopag 25mg comes in packs of 28 and 56 tablets. The lowest price works out at about $7.14 per tablet on the 56 tablet pack, as of October 2026; the pack selector shows the current price. Shipping is $25 on orders under $149 and free from $149.
Prescription status
Eltrombopag is a prescription medicine in the US, UK, Australia and Canada. Rebopag 25mg itself is an India made pack and is not approved by the FDA, MHRA, TGA or Health Canada. The FDA says that importing unapproved medicines for personal use is illegal in most circumstances, so check the rules where you live.
Before you order
Read the patient leaflet that comes with the pack. Tell your doctor or pharmacist about any other medicines you take and any health conditions you have. Get urgent medical help if you notice signs of an allergic reaction, such as swelling of the face, lips, tongue or throat, trouble breathing, or a widespread rash.
Delivery
Orders usually arrive in 7 to 14 business days in plain packaging, with a tracking number.
Key Information
- βActive Ingredient: Eltrombopag
- βCategory: Life Saving Drugs
- βForm: Tablet
- βBrand: Rebopag
- βManufacturer: MSN Laboratories
Frequently Asked Questions
What is Rebopag 25mg?
Rebopag 25mg is an Indian brand of eltrombopag 25 mg, a thrombopoietin receptor agonist that raises platelet counts, made by MSN Laboratories.
What is Rebopag 25mg used for?
The US FDA label for Promacta (DailyMed) lists low platelets in persistent or chronic immune thrombocytopenia (ITP) in adults and children 1 year and older when other treatments were not enough, low platelets in chronic hepatitis C so that interferon treatment can start or continue, and severe aplastic anemia; it is not for myelodysplastic syndrome. Your doctor decides whether it is right for you.
Do I need a prescription for eltrombopag?
Eltrombopag is a prescription medicine in the US, UK, Australia and Canada. This India made pack is not approved by the FDA, MHRA, TGA or Health Canada.
How long does delivery of Rebopag 25mg take?
Orders usually arrive in 7 to 14 business days in plain packaging, with tracking.
Related Products
View allCustomer Reviews
No reviews yet. Be the first to review Rebopag 25mg.
Related Articles
Health guides about Eltrombopag, written by pharmacists

Brand vs Generic Drug Prices: What US Pharmacies Pay for Viagra, Cialis, Latisse and More (NADAC, October 2026)
CMS NADAC data for the week of 14 October 2026 shows what US pharmacies pay for brand and generic versions of Viagra, Cialis, Propecia, Latisse, Lumigan and Stromectol. Generic ED and hair loss tablets cost under 2% of the brand price, while eye and lash generics cost 41% to 65%. Includes 2026 trends, supplier counts and the full method.

Buy Amaryl (Glimepiride) Online: Dosing, Hypoglycaemia Risk and What to Verify First
Amaryl is brand name glimepiride, a sulfonylurea that lowers blood sugar effectively and cheaply but carries real hypoglycaemia risk. Dosing, the CAROLINA trial evidence, interactions, and what to verify before ordering online.

Generic vs Branded Medicines: What You Really Need to Know
Many patients assume branded drugs are superior to generics. The truth, backed by decades of FDA research, is more nuanced.




